IRIS Accounts Production v25.1.4.42 12256114 Board of Directors 1.11.23 31.10.24 31.10.24 false true false false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh122561142023-10-31122561142024-10-31122561142023-11-012024-10-31122561142022-10-31122561142022-11-012023-10-31122561142023-10-3112256114ns15:EnglandWales2023-11-012024-10-3112256114ns14:PoundSterling2023-11-012024-10-3112256114ns10:Director12023-11-012024-10-3112256114ns10:PrivateLimitedCompanyLtd2023-11-012024-10-3112256114ns10:SmallEntities2023-11-012024-10-3112256114ns10:AuditExempt-NoAccountantsReport2023-11-012024-10-3112256114ns10:SmallCompaniesRegimeForDirectorsReport2023-11-012024-10-3112256114ns10:SmallCompaniesRegimeForAccounts2023-11-012024-10-3112256114ns10:FullAccounts2023-11-012024-10-311225611412023-11-012024-10-3112256114ns10:Director22023-11-012024-10-3112256114ns10:Director32023-11-012024-10-3112256114ns10:RegisteredOffice2023-11-012024-10-3112256114ns5:CurrentFinancialInstruments2024-10-3112256114ns5:CurrentFinancialInstruments2023-10-3112256114ns5:ShareCapital2024-10-3112256114ns5:ShareCapital2023-10-3112256114ns5:RetainedEarningsAccumulatedLosses2024-10-3112256114ns5:RetainedEarningsAccumulatedLosses2023-10-3112256114ns5:IntangibleAssetsOtherThanGoodwill2023-11-012024-10-3112256114ns5:PatentsTrademarksLicencesConcessionsSimilar2023-11-012024-10-3112256114ns5:PatentsTrademarksLicencesConcessionsSimilar2023-10-3112256114ns5:PatentsTrademarksLicencesConcessionsSimilar2024-10-3112256114ns5:PatentsTrademarksLicencesConcessionsSimilar2023-10-3112256114ns5:PlantMachinery2023-10-3112256114ns5:PlantMachinery2023-11-012024-10-3112256114ns5:PlantMachinery2024-10-3112256114ns5:PlantMachinery2023-10-3112256114ns5:WithinOneYearns5:CurrentFinancialInstruments2024-10-3112256114ns5:WithinOneYearns5:CurrentFinancialInstruments2023-10-31122561141ns10:Director12023-10-31122561141ns10:Director12022-10-31122561141ns10:Director12023-11-012024-10-31122561141ns10:Director12022-11-012023-10-31122561141ns10:Director12024-10-31122561141ns10:Director12023-10-31122561143ns10:Director32023-10-31122561143ns10:Director32022-10-31122561143ns10:Director32023-11-012024-10-31122561143ns10:Director32022-11-012023-10-31122561143ns10:Director32024-10-31122561143ns10:Director32023-10-31
REGISTERED NUMBER: 12256114 (England and Wales)




















Unaudited Financial Statements

for the Year Ended 31 October 2024

for

BriXcell Ltd

BriXcell Ltd (Registered number: 12256114)






Contents of the Financial Statements
for the Year Ended 31 October 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


BriXcell Ltd

Company Information
for the Year Ended 31 October 2024







DIRECTORS: T M Gardner
B N Glover
W J McFarlane





REGISTERED OFFICE: Unit 2 Global Business Park
Wilkinson Road
Cirencester
Gloucestershire
GL7 1US





REGISTERED NUMBER: 12256114 (England and Wales)

BriXcell Ltd (Registered number: 12256114)

Balance Sheet
31 October 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 5 24,702 24,824
Tangible assets 6 74,181 78,085
98,883 102,909

CURRENT ASSETS
Stocks 7 16,250 14,506
Debtors 8 9,361 2,148
Cash at bank 7,590 2,624
33,201 19,278
CREDITORS
Amounts falling due within one year 9 61,113 44,835
NET CURRENT LIABILITIES (27,912 ) (25,557 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

70,971

77,352

CAPITAL AND RESERVES
Called up share capital 102,102 102,102
Retained earnings (31,131 ) (24,750 )
70,971 77,352

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 July 2025 and were signed on its behalf by:





T M Gardner - Director


BriXcell Ltd (Registered number: 12256114)

Notes to the Financial Statements
for the Year Ended 31 October 2024

1. STATUTORY INFORMATION

The company is a private company limited by shares, registered in 01/10/2019. The address of the registered office is Unit 2 Global Business Park, Wilkinson Road, Cirencester, Gloucestershire, GL7 1YZ.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the financial currency of the entity.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of nil years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Stocks
Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Costs includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.

Going concern
The directors have considered going concern and believe this to be an appropriate basis on which to prepare these accounts. The directors have agreed to continue to support the company to ensure that it can meet its obligations as they fall due.

Revenue recognition
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Impairment of fixed assets
A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date.

For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets.

For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

BriXcell Ltd (Registered number: 12256114)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2024

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

5. INTANGIBLE FIXED ASSETS
Patents
and
licences
£   
COST
At 1 November 2023 24,824
Additions 1,178
At 31 October 2024 26,002
AMORTISATION
Amortisation for year 1,300
At 31 October 2024 1,300
NET BOOK VALUE
At 31 October 2024 24,702
At 31 October 2023 24,824

6. TANGIBLE FIXED ASSETS
Plant and
machinery
£   
COST
At 1 November 2023
and 31 October 2024 78,085
DEPRECIATION
Charge for year 3,904
At 31 October 2024 3,904
NET BOOK VALUE
At 31 October 2024 74,181
At 31 October 2023 78,085

7. STOCKS
2024 2023
£    £   
Stocks 16,250 14,506

8. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 8,124 1,746
VAT 1,237 402
9,361 2,148

BriXcell Ltd (Registered number: 12256114)

Notes to the Financial Statements - continued
for the Year Ended 31 October 2024

9. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 15,310 11,112
Other creditors 14,966 10,966
Directors' current accounts 29,932 21,932
Accruals and deferred income 905 825
61,113 44,835

10. FINANCIAL INSTRUMENTS

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

11. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 October 2024 and 31 October 2023:

2024 2023
£    £   
T M Gardner
Balance outstanding at start of year (14,966 ) (6,966 )
Amounts advanced - (8,000 )
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (14,966 ) (14,966 )

W J McFarlane
Balance outstanding at start of year (6,966 ) (6,966 )
Amounts advanced (8,000 ) -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year (14,966 ) (6,966 )